WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) II L.P. reported 1 transaction at RAYZEBIO, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/19/2023ACC: 0000950170-23-048874
→
10% Owner
Since Sep 2023
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.56M acquired · 1.56M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.56M
Price / share
—
Trade value
—
% of position
New position
9/19/2023
0.00→1.56M
Total
Net shares
+1.56M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/19/2023 | C · Conversion | +1.56M | — | — | New position | 0.00 | 1.56M |
| Total | +1.56M | $0.00 | ||||||
Derivative Transactions1
Series D Preferred Stock
Direct
Converts to
Common Stock
1.56M shares
Shares
−1.56M
Strike price
Held after
0.00
Exercisable
—
9/19/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series D Preferred Stock Direct | Common Stock1.56M shares | 9/19/2023 | C · Conversion | −1.56M | — | 0.00 |